FLAVIVIRUSÄHNLICHE PARTIKEL

Patent europeic · EP3191589 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3191589
Numer da la dumonda
EP15840429
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-09-2015
Publitgà
19-07-2017
Concedì
26-11-2025
La protecziun finescha il pli tard
09-09-2035
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
C12N 15/09 (2006.01)
C07K 19/00 (2006.01)
C07K 14/005 (2006.01)
A61K 39/12 (2006.01)
C12N 7/00 (2006.01)
Prioritad
US 201462048897 P 11.09.2014
Dumonda PCT
PCT/JP2015/004623 10.09.2015
Publicaziun PCT
WO2016/038895 17.03.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 07-10-2026

    Midada

    Published in Swissreg on 07.10.2026

  2. 26-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.11.2025

Partidas

Possessur

VLP Therapeutics, Inc.

1209 Orange Street, Wilmington, DE 19801, US

Inventur

AKAHATA, Wataru

Kensington, Maryland 20895, US

UENO, Ryuji

Easton, Maryland 21601, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.